Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998

被引:0
作者
W. Thierfelder
W. Hellenbrand
H. Meisel
E. Schreier
R. Dortschy
机构
[1] Robert Koch-Institut,
[2] Humboldt-Universität Berlin,undefined
[3] Charité,undefined
来源
European Journal of Epidemiology | 2001年 / 17卷
关键词
Cross-sectional study; Germany; Hepatitis A; Hepatitis B; Hepatitis C; Prevalence; Survey;
D O I
暂无
中图分类号
学科分类号
摘要
The prevalence of serological parameters indicative of infection with hepatitis A, B and C was determined using sera collected from representative population samples in the former East German (new) federal states and the West German (old) federal states during the German National Health and Examination Survey in 1998. Sera were tested for antibodies to hepatitis A virus (HAV), to hepatitis B core antigen (HBc) and to hepatitis B surface antigen (HBsAg), hepatitis C Virus (HCV), as well as for the presence of HBsAg and HCV-RNA. The mean weighted prevalence of anti-HAV was 46.5% (95% CI: 45.3–47.7) and increased markedly with age. The mean weighted prevalence of past infection with hepatitis B was 7.7% (95% CI: 7.0–8.4) in the old federal states and 4.3% (95% CI: 3.2–5.3) in the new federal states, corresponding to an overall prevalence of 7.0% (95% CI: 6.4–7.6). The mean weighted prevalence of HBsAg carriage was 0.6% (95% CI: 0.4–0.8), while the prevalence of HCV antibodies was 0.4% (95% CI: 0.2–0.5).
引用
收藏
页码:429 / 435
页数:6
相关论文
共 80 条
[1]  
Bellach B-M(2000)Zur Situation bei wichtigen Infektionskrankheiten imJahr 1999. Teil 2: Virushepatitiden Epidemiologisches Bulletin 28 223-227
[2]  
Knopf H(1998)Der Bundes-Gesundheitssurvey 1997–1998 Gesundheitswesen 60 S59-S68
[3]  
Thefeld W.(1999)DeBundes-Gesundheitssurvey: Response, Zusammensetzung der Teilnehmer und Non-Responder-Analyse Gesundheitswesen 61 S57-S61
[4]  
Thefeld W(1994)Praevalenz von Hepatitis-A-Virus-Antikoerpern bei Krankenhauspersonal Gesundheitswesen 56 377-379
[5]  
Stolzenberg H(1992)Hepatitis A as an occupational hazard Vaccine 10 S82-S84
[6]  
Bellach B-M.(1993)Hepatitis-A-Infektionsrisiko bei den Mitarbeitern einer grossen Kla¨ ranlagenbetreibergenbossenschaft Arbeitsmedizin Sozialmedizin Praventivmedizin 28 503-505
[7]  
Abb J.(1994)Folgen importierter Tropenkrankheiten in Deutschland Versicherungsmedizin 46 135-137
[8]  
Hofmann F(1979)Antibody against hepatitis A in seven European countries. II. Statistical analysis of cross-sectional surveys AmJ Epidemiol 110 70-76
[9]  
Wehrle G(1993)Prevalence of Hepatitis A antibodies in Swiss travellers Eur J Epidemiol 9 50-54
[10]  
Berthold H(1994)Hepatitis A in western Austria – the epidemiologic situation before the introduction of active immunisation Infection 22 53-55